A low-energy total diet replacement programme demonstrates a favourable safety profile and improves liver disease severity in non-alcoholic steatohepatitis

<p><strong>Objective:</strong> Low-energy diets are used to treat obesity and diabetes, but there are fears that they may worsen liver disease in patients with nonalcoholic steatohepatitis (NASH) and significant-to-advanced fibrosis.</p> <p><strong>Methods:</s...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Koutoukidis, D, Mozes, F, Jebb, S, Tomlinson, J, Pavlides, M, Saffioti, F, Huntriss, R, Aveyard, P, Cobbold, J
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	Wiley 2023

Míreanna comhchosúla

Association of weight changes with changes in histological features and blood markers in non-alcoholic steatohepatitis
de réir: Koutoukidis, D, et al.
Foilsithe / Cruthaithe: (2021)

Association of changes in histological severity of non-alcoholic steatohepatitis and changes in patient-reported quality of life
de réir: Heath, L, et al.
Foilsithe / Cruthaithe: (2022)

Changes in intestinal permeability and gut microbiota following diet-induced weight loss in patients with metabolic dysfunction-associated steatohepatitis and liver fibrosis
de réir: Dimitrios A. Koutoukidis, et al.
Foilsithe / Cruthaithe: (2024-12-01)

Association of changes in histologic severity of nonalcoholic steatohepatitis and changes in patient‐reported quality of life
de réir: Laura Heath, et al.
Foilsithe / Cruthaithe: (2022-10-01)

What proportion of people have a follow-up biopsy in randomized trials of treatments for non-alcoholic steatohepatitis?: A systematic review and meta-analysis
de réir: Koutoukidis, DA, et al.
Foilsithe / Cruthaithe: (2021)

Heterogeneity in the uptake, attendance and outcomes in a clinical trial of a total diet replacement weight loss programme
de réir: Astbury, N, et al.
Foilsithe / Cruthaithe: (2020)

Extended follow-up of a short total diet replacement programme: results of the Doctor Referral of Overweight People to Low Energy total diet replacement Treatment (DROPLET) randomised controlled trial at 3 years
de réir: Astbury, N, et al.
Foilsithe / Cruthaithe: (2021)

Is doctor referral to a low-energy total diet replacement programme cost-effective for the routine treatment of obesity?
de réir: Kent, S, et al.
Foilsithe / Cruthaithe: (2019)

What proportion of people have a follow-up biopsy in randomized trials of treatments for non-alcoholic steatohepatitis?: A systematic review and meta-analysis.
de réir: Dimitrios A Koutoukidis, et al.
Foilsithe / Cruthaithe: (2021-01-01)

Heterogeneity in the uptake, attendance, and outcomes in a clinical trial of a total diet replacement weight loss programme
de réir: Nerys M. Astbury, et al.
Foilsithe / Cruthaithe: (2020-04-01)

Non-alcoholic fatty liver disease
de réir: Pavlides, M, et al.
Foilsithe / Cruthaithe: (2019)

Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
de réir: Dowman, J, et al.
Foilsithe / Cruthaithe: (2011)

The Influence of Different Fat Sources on Steatohepatitis and Fibrosis Development in the Western Diet Mouse Model of Non-alcoholic Steatohepatitis (NASH)
de réir: Hannah K. Drescher, et al.
Foilsithe / Cruthaithe: (2019-06-01)

Role of alcohol metabolism in non-alcoholic steatohepatitis.
de réir: Susan S Baker, et al.
Foilsithe / Cruthaithe: (2010-03-01)

Guidelines for liver transplantation for patients with non-alcoholic steatohepatitis.
de réir: Newsome, P, et al.
Foilsithe / Cruthaithe: (2012)

Therapeutic approaches for non-alcoholic steatohepatitis
de réir: Luc F. Van Gaal, et al.
Foilsithe / Cruthaithe: (2021-09-01)

Participant experiences of a low-energy total diet replacement programme: a descriptive qualitative study
de réir: Astbury, N, et al.
Foilsithe / Cruthaithe: (2020)

Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis.
de réir: Armstrong, M, et al.
Foilsithe / Cruthaithe: (2015)

Non-alcoholic Steatohepatitis: An Overview
de réir: Allison Shifflet, et al.
Foilsithe / Cruthaithe: (2009-01-01)

Endocannabinoids and non-alcoholic steatohepatitis
de réir: Helmy Ahmed
Foilsithe / Cruthaithe: (2006-01-01)

Statins in Non-alcoholic Steatohepatitis
de réir: Jose D. Torres-Peña, et al.
Foilsithe / Cruthaithe: (2021-11-01)

Fructose and Non-Alcoholic Steatohepatitis
de réir: Elke Roeb, et al.
Foilsithe / Cruthaithe: (2021-02-01)

Caspase-1 as a central regulator of high fat diet-induced non-alcoholic steatohepatitis.
de réir: Laura J Dixon, et al.
Foilsithe / Cruthaithe: (2013-01-01)

Participant experiences of a low-energy total diet replacement programme: A descriptive qualitative study.
de réir: Nerys M Astbury, et al.
Foilsithe / Cruthaithe: (2020-01-01)

The effect of moderate weight loss on a non-invasive biomarker of liver fibrosis: a randomised controlled trial
de réir: Koutoukidis, DA, et al.
Foilsithe / Cruthaithe: (2020)

Albumin-fused thioredoxin ameliorates high-fat diet-induced non-alcoholic steatohepatitis
de réir: Ryota Murata, et al.
Foilsithe / Cruthaithe: (2024-02-01)

Overexpression of ORMDL3 confers sexual dimorphism in diet-induced non-alcoholic steatohepatitis
de réir: Ryan D.R. Brown, et al.
Foilsithe / Cruthaithe: (2024-01-01)

Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis
de réir: Henrik H. Hansen, et al.
Foilsithe / Cruthaithe: (2020-07-01)

Methionine- and choline-deficient diet induces hepatic changes characteristic of non-alcoholic steatohepatitis
de réir: Éder Marcolin, et al.
Foilsithe / Cruthaithe: (2011-03-01)

Hepatoprotective effect of Qushihuayu formula on non-alcoholic steatohepatitis induced by MCD diet in rat
de réir: Qingping Lan, et al.
Foilsithe / Cruthaithe: (2021-03-01)

Abdominal subcutaneous adipose tissue insulin resistance and lipolysis in patients with non-alcoholic steatohepatitis
de réir: Armstrong, M, et al.
Foilsithe / Cruthaithe: (2014)

Abdominal subcutaneous adipose tissue insulin resistance and lipolysis in patients with non-alcoholic steatohepatitis.
de réir: Armstrong, M, et al.
Foilsithe / Cruthaithe: (2014)

Correlations between MRI biomarkers PDFF and cT1 with histopathological features of non-alcoholic steatohepatitis
de réir: Dennis, A, et al.
Foilsithe / Cruthaithe: (2021)

Comparison of clinical, biochemical and histological features of alcoholic steatohepatitis and non-alcoholic steatohepatitis in Asian Indian patients
de réir: Singh Deepak, et al.
Foilsithe / Cruthaithe: (2010-07-01)

Participant experiences of a low-energy total diet replacement programme: A descriptive qualitative study
de réir: Nerys M. Astbury, et al.
Foilsithe / Cruthaithe: (2020-01-01)

Liraglutide for patients with non-alcoholic steatohepatitis.
de réir: Dale, A, et al.
Foilsithe / Cruthaithe: (2016)

Association of weight loss interventions with changes in biomarkers of non-alcoholic fatty liver disease: A systematic review and meta-analysis
de réir: Koutoukidis, DA, et al.
Foilsithe / Cruthaithe: (2019)

Fermented field water-dropwort (Oenanthe javanica) alleviates diet-induced non-alcoholic steatohepatitis
de réir: Dong Hun Lee, et al.
Foilsithe / Cruthaithe: (2022-12-01)

Multi-parametric MRI can diagnose steatohepatitis and cirrhosis in patients with NAFLD
de réir: Pavlides, M, et al.
Foilsithe / Cruthaithe: (2014)

Adipocytes disrupt the translational programme of acute lymphoblastic leukaemia to favour tumour survival and persistence
de réir: Q. Heydt, et al.
Foilsithe / Cruthaithe: (2021-09-01)